Pretty much acgree. However about Elanco you mustn't also forget that
!. they are currently under financial pressure 2. under major legal challenge from distributors 3. in the midst of a massive re-organisation as they merge with another animal health major and so its quite normal under such circumstances to put a halt on many prospective projects
In reality it's very hard to draw any conclusions from their action with such a convergence of circumstances.
But what we do know is the MPL pill works in dogs because months after the trial finished, vets who participated are voluntarity choosing to continue using the MPL tablet to treat dogs suffering B cell lymphoma, which is an ultra aggressive cancer that kills untreated dogs in a very short period of time. And now we also have the MND trial coming up and being financed by a charity as well as the ongoing covid lab trial at Leiden after a very successful start at WEHI.
On Buckland's point, I agree, it's a matter of how long and much investors can hold out and that's a very individual thing. However, I expect that if the current Leiden University covid testing proves positive and opens the way to organoid testing there, that would probably give the stock some support going into next year. I hope.
PAA Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)